Back to Results
First PageMeta Content
Economics / Stock / Calcification / Fundamental analysis / Financial economics / Stock market / Investment


Bioshares Number 492 – 22 February 2013 In this edition... Universal Biosensors has made very good
Add to Reading List

Document Date: 2013-11-26 02:02:20


Open Document

File Size: 28,16 KB

Share Result on Facebook

City

Brisbane / /

Company

Starpharma Holdings / Industry & Market Analysis Pty Ltd. / Allied Health Allied Healthcare Group / Market Analysis Pty Ltd. / Merck Canada / How Bioshares / Allied Healthcare Group / Atcor / Biota Holdings / Coridon / Siemens / /

Continent

Europe / /

Currency

USD / /

/

Event

Funding / FDA Phase / /

Facility

Royal Children’s Hospital / University of Western Australia / Mater Hospital / /

/

IndustryTerm

healthcare / tissue product / vaccine technology / patch product / tissue patch product / coagulation test devices / /

MedicalCondition

cuts / congenital heart disease / congenital heart defects / hernia / /

Organization

Mater Hospital in Brisbane / University of Western Australia / Royal Children’s Hospital in Melbourne / FDA / European Union / /

Person

Lee Rodne / Bioshares Ph / Mark Pachacz / David Blake / /

/

Position

Editor / CEO / investment adviser / surgeon / /

Product

Cardiocel / Cardiocel tissue patch product / HSV vaccine / HSV2 / /

ProvinceOrState

Western Australia / /

Region

Western Australia / /

Technology

Biosensors / Av / Biotechnology / same technologies / CMP / one technology / DNA vaccine technology / ADAPT processing technology / /

SocialTag